- Filed
- Mar 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 45.45M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $119.97M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $96.67M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $311.52M |
| Current Assets | FY 2024 · Dec 31, 2023 | $546.79M |
| Total Assets | FY 2024 · Dec 31, 2023 | $787.67M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 48.23K sh |
| Capex | FY 2024 · Dec 31, 2022 | $8.2M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $57.8M |
| Eps Diluted restated | FY 2024 · Dec 31, 2022 | $1.68 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $1.81 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $49.5M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $28.86M |
| Net Income | FY 2024 · Dec 31, 2022 | $79.95M |
| Operating Income | FY 2024 · Dec 31, 2022 | $81.5M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $159.86M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $161.05M |
| Revenue | FY 2024 · Dec 31, 2022 | $320.91M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $293.63M |